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a  b  s  t  r  a  c  t
Background:  Human  Norovirus  (NoV)  is recognized  as  a major  etiological  agent  of sporadic  acute  gas-
troenteritis  worldwide.
Objectives: This  study  describes  the  clinical  features  associated  with Human  NoV  occurrence  in children
and  determines  the  prevalence  and estimated  viral  burden  of NoV  in symptomatic  and  asymptomatic
children  in rural  South  Africa.
Study  design:  Between  July  2014  and April  2015,  outpatient  children  under  5 years  of age  from  rural
communities  of Vhembe  district,  South  Africa, were  enrolled  for the  study.  A total  of 303  stool  specimens
were  collected  from  those  with  diarrhea  (n = 253)  and  without  (n = 50)  diarrhea.  NoVs  were  identiﬁed
using  real-time  one-step  RT-PCR.
Results:  One  hundred  and four  (41.1%)  NoVs  were  detected  (62[59.6%]  GII,  16[15.4%]  GI, and  26[25%]
mixed  GI/GII)  in cases  and  18  (36%)  including  9(50%)  GII, 2(11.1%)  GI  and  7(38.9%)  mixed  GI/GII in  controls.
NoV  detection  rates  in  symptomatic  and  asymptomatic  children  (OR  = 1.24;  95%  CI 0.66–2.33)  were  not
signiﬁcantly  different.  Comparison  of the median  CT values  for NoV  in symptomatic  and  asymptomatic
children  revealed  signiﬁcant  statistical  difference  of  estimated  GII viral  load  from  both  groups,  with  a
much  higher  viral  burden  in symptomatic  children.
Conclusions:  Though  not  proven  predictive  of diarrhea  disease  in this  study,  the  high  detection  rate  of NoV
reﬂects  the  substantial  exposure  of  children  from  rural  communities  to enteric  pathogens  possibly  due
to poor  sanitation  and  hygiene  practices.  The  results  suggest  that the  difference  between  asymptomatic
and  symptomatic  children  with  NoV  may  be at the  level  of the viral  load  of NoV  genogroups  involved.
© 2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Background
More than 70% of African people who live in poverty, reside
n rural areas [1,2]. Subsequently illiteracy, malnutrition, inade-
uate water supplies and poor sanitation, as well as poor health and
ygiene practices, affect a large proportion of rural communities in
he African continent.
Abbreviations: PHC, public health care; IC, internal control; ROC, receiver oper-
ting characteristic; Inv, inverse; RSA, Republic of South Africa; UK, United Kingdom.
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With the considerable decline of rotavirus-associated diarrhea
in countries that have introduced rotavirus vaccines, NoV is increas-
ingly recognized as a leading cause of acute gastroenteritis [3,4].
The symptoms associated with NoV infection, which mani-
fest after an incubation period of 1–2 days (95% CI 1.1–1.2 days)
[5], are typically self-limiting, characterised by nausea, vomiting,
abdominal pain and non-bloody diarrhea (4–8 stools per day). The
duration of NoV illness is typically 12–72 h [6] but the illness can
be prolonged (and severe) in the very young or old, and immuno-
compromised persons [7,8]. However, reports have revealed that
not all individuals develop symptoms and a signiﬁcant proportion
remains asymptomatic after NoV infections [9–11]. Several stud-
ies have suggested that the semi-quantitative measure of real-time
RT-PCR as a proxy measure of fecal viral load using threshold cycles
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CT) value may  distinguish between asymptomatic viral shedding
rom clinically relevant disease [12–14].
Studies have shown that children from poor communities in
eveloping countries with poor standards of hygiene, including
nsafe disposal of faeces and the use of contaminated water sup-
lies can facilitate the transmission of NoV [15–17]. Nevertheless
ost of the NoV studies in Africa have been carried out in urban
ettings, likely due to the lack of laboratory capacity for Human
oV detection in rural settings [18]. In South Africa, little has been
eported on the prevalence and circulating NoV genotypes across
he country [18–20].
. Objectives
To determine the prevalence of NoVs in asymptomatic and
ymptomatic children in rural communities of Vhembe dis-
rict/South Africa and to compare the differences in viral burden
s suggested by the RT-PCR CT value.
. Study design
This study was a cross-sectional, clinic-based investigation of
ut-patients, conducted from July 2014 to April 2015. Stool sam-
les were randomly collected at different clinics situated within the
ural communities of Vhembe District in Limpopo Province, South
frica. In South Africa, most cases of intestinal gastroenteritis are
een by the PHC centres (clinics) situated in the rural communities
nd only the severe cases (with dehydration) are directed by the
linic nurses to the hospitals. A total of 40 clinics were designated
ampling sites for this study. Samples were transported to the Uni-
ersity of Venda Microbiology laboratory and tested for NoV by
T-PCR.
.1. Clinical samples
.1.1. Informed and ethical consent
The study protocol and consent procedures were approved
y the Ethics committees of the Department of Health in the
impopo Province (Ref. 4/2/2) and University of Venda (Ref.
MNS/13/MBY/0212). Written, informed consent was  given by the
arent or guardian of the child before stool sample collection.
.1.2. Capture forms for data collection
\After consent was given, personal details (date of birth, sex,
ate of diarrhea onset) as well as clinical data such as presence of
ever, vomiting, abdominal pain or dehydration were collected. The
onsistency of the stool (according to the Bristol stool chart) was
ocumented. The parent employment status as well as the family
iving conditions such as the source of water, presence of livestock
nd toilet seat use was also recorded.
.1.3. Sample collection
One stool sample from each child under 5 years of age, who pre-
ented to the clinic with diarrhea, was collected by the clinic nurse
nd kept at + 4 ◦C. Diarrhea was deﬁned as three or more episodes
f watery stool in the previous 24 h [21]. Stool specimens were
ollected from clinics on a weekly basis, transported on ice to the
aboratory within 6 h and stored at − 20 ◦C until tested.
A total of 253 stool samples from symptomatic cases were col-
ected for this study. Stool samples from patients with bloody
iarrhea were excluded.
Fifty stool samples from healthy controls (children under 5 years
ttending the clinic for routine immunization with no episodes of
cute gastroenteritis in the previous 30 days) were also collected.l Virology 84 (2016) 12–18 13
3.2. RNA extraction, NoV detection and characterisation
The Boom method was employed to extract NoV RNA as
previously described [22]. The method is based on the lysing
and nuclease inactivating properties of the chaotropic agent
guanidinium thiocyanate, together with the nucleic acid-binding
proprieties of silica particles.
- RIDA© GENE NOROVIRUS I & II real-time RT-PCR (r-Biopharm
AG, Darmstadt, Germany) kits were used to detect NoV from clini-
cal samples in this study. This PCR assay offers qualitative detection
and differentiation of NoV genogroup I and II in human stool
samples according to the manufacturer and it is not thought to
cross-react with other common enteric pathogens. RIDA gene kit
can also detect GIV genogroup. The assay has 98% of sensitivity
and speciﬁcity [23] and includes an internal control to monitor
for extraction efﬁciency and ampliﬁcation inhibition. The test is
carried out in a one-step real-time RT-PCR format in which the
reverse transcription of RNA is followed by the PCR in the same
tube. The real-time PCR program was performed on a Corbett
Research Rotor Gene 6000 with the following cycling conditions:
Reverse transcription for 10 min  at 58 ◦C; initial denaturation
step for 1 min  at 95 ◦C followed by 45 cycles of 95 ◦C for 15 s
and 55 ◦C for 30 s with continuous ﬂuorescence reading. Sepa-
rate rooms were used for the pre- and post-ampliﬁcation steps
to minimise the risk of amplicon carry-over and contamination of
samples.
Randomly selected stool RNA extracts, which tested NoV
positive, were subjected to RT-PCR ampliﬁcation using primers
from previously published work, for the purpose of sequencing
to conﬁrm the detection results. The One step Ahead RT-PCR
(QIAGEN) was  used, utilising speciﬁc oligonucleotide primer
sets GISKF/GISKR to amplify 330 bp of GI capsid fragment and
GIISKF/GIISKR for 344 bp of GII capsid fragment as previously
described [24]. The PCR products of the ampliﬁed fragments
were directly puriﬁed with a master mix  of ExoSAP (Nucleics,
Australia). Using the same speciﬁc primers, the Sanger sequenc-
ing was  performed on the ABI 3500XL Genetic Analyzer POP7TM
(Thermo-Scientiﬁc).
The nucleotide sequences were compared with those of the
reference strains available in the NCBI GenBank using BLAST tool
available at http://www.ncbi.nlm.nih.gov/blast then analysed for
their genotypes using Noronet typing tools [25] available at http://
www.rivm.nlm/norovirus/typingtool
3.3. Statistical analyses
Data was  initially recorded in Microsoft Excel. All analyses were
done by STATA v13. Logistic regression of being NoV positive, using
the following predictors: types of water sources, speciﬁc symptoms
and whether or not the patient had watery stool, was calculated.
Mann-Whitney U, Wilcoxon W,  Z test and a t-test comparing CT val-
ues in cases and controls were performed. Non-parametric receiver
operating characteristic analyses to assess the association between
CT values and illness were also performed.
A P-value of < 0.05 was  considered to be statistically signiﬁcant.
4. Results
4.1. Study characteristics
From July 2014 to April 2015, a total of 303 fecal samples, includ-
ing 253 specimens from cases and 50 from healthy controls, were
collected and examined for NoV. The median age was  10 months
(range 1–60 months) in the symptomatic group and the sex dis-
tribution was 53.4% (135/253) male, 46.6% (118/253) female. In
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Table 1
Demographic proﬁle of NoV-positive in children under 5 years of age from rural communities of Vhembe district, South Africa.
Case-patients Controls
Total No of positive (%) Total No of positive (%)
Detection rates (%) 253 104 (41,1) 50 18(36)
Age  range (month)
0−6 86 37(43,0) 9 6(66,7)
7–12  68 28(41,2) 15 4(26,7)
13–24  65 31(47,7) 16 5(31,2)
25–60  34 8(23,5) 10 3(30,0)
Gender
Male  135 51(37,8) 25 10(40,0)
Female 118 53(44,9) 25 8(32,0)
Table 2
Clinical features of study participant children under 5 years of age from rural communities of Vhembe district, South Africa.
Case-patients (n = 253) Controls (n = 50)
Parameter NoV positive (%) n = 104 NoV negative (%) n = 149 NoV positive (%) n = 18
Symptoms
Diarrhoea only 59 (56.7) 83 (55.7)
Diarrhoea+ other symptoms 45 (43.3) 66 (44.3)
Other reported symptoms
Dehydration 11 (10.6) 13 (8.7)
Vomiting 28 (26.9) 35 (23.5)
Anorexia 10 (9.6) 18 (12.1)
Fever 20 (19.2) 28 (18.8)
Type of stool
Watery 52 (50.0) 58 (38.9) 0
Formed 34 (32.7) 55 (36.9) 12 (66.7)




























c≤ 3days 87 (83.6) 
3  days 17 (16.4) 
a Between the onset of diarrhea and collection of stool.
he control group the median age was 13 months (range 1–55
onths) and this cohort was comprised of 50% (25/50) male and
0% (25/50) female participants. The most common clinical features
f the symptomatic children were with diarrhea only (reported in
6.1% [142/253]) and diarrhea with vomiting (24.9% [63/253]). The
emographic proﬁles and clinical characteristics of study partici-
ant children are described in Tables 1 and 2.
.2. Norovirus prevalence and characterisation
Of the 253 fecal samples from symptomatic children, 104 were
ositive for NoV (41.1%; 95%CI 35.0-47.4%). Of these positive sam-
les 62 [59.6%] were GII only, 16 [15.4%] were GI, and 26 [25%] were
I/GII mixed in symptomatic children. Of 50 control samples 18
ere positive for NoV (36.0%; 95%CI 22.9-50.8%) including 9 (50%)
II, 2 (11.1%) GI and 7 (38.9%) G/GII mixed. The prevalence of NoV
as higher in cases (OR = 1.24; 95% CI 0.66–2.33) though this was
ot statistically signiﬁcant. Looking at each genotype whether as
ingle agent or in combination, GI was detected in 42 (17%) of cases
nd 9 (18%) of controls and GII in 88 (35%) of cases and 16(32%) of
ontrols. These differences were also not statistically signiﬁcant.
The highest detection rate of NoV, in case patients, was found in
he age group of 13–24 months (47.7%, 31/65) (Table 1). NoVs were
redominantly detected from children presenting with liquid stool
50%, 52/104) (Table 2). There is a suggestion that liquid stool is
ssociated with NoV positivity, but this was not statistically signif-
cant (Odds Ratio = 1.58; 95% CI 0.98–2.5). Also, no risk factor has
een found with NoVs genogroup as a predictor of symptomatic
ases (Appendix S1).7 (85.2)
 (14.8)
As can be seen from Table 2 there is no difference in reported
symptoms between case patients positive for NoV and case patients
negative for NoV.
Temporal distribution of NoV genogroups between July 2014
and April 2015 showed NoV detection every month throughout the
study period with a possible peak in October 2014 (Fig. 1).
NoV-G2SKF/G2SKR amplicons of samples number 30, 45,
148 and NoV-G1SKF/G1SKR amplicons of samples number 139,
168, H011 were sequenced. A BLAST search conﬁrmed that the
sequenced samples were Human NoV (KJP-30C-Venda-2014, KJP-
45C-Venda-2014, KJP-148C-Venda-2014, KJP-139C-Venda-2014,
KJP-168C-Venda-2015, and KJP-H011C-Venda-2015). Noronet
genotyping tool identiﬁed respectively the following Norovirus
strains: GII.4 variant (n = 2), GII.14 (n = 1), GI.4 (n = 2) and GI.5 (n = 1)
(Table 3).
4.3. Human NoV viral load in fecal specimens
There was a considerable variation in NoV CT values in positive
samples from both symptomatic cases and asymptomatic controls
(Fig. 2). The median CT value of NoV GII genogroup in symptomatic
was lower (27.02) than in asymptomatic children (34.59) and this
was statistically signiﬁcant (p = 0.0009 Kruskal-Wallis equality-of-
populations rank test) (Fig. 2). However, there was no difference in
median CT value between symptomatic (28.06) and asymptomatic
(27.58) participants for NoV GI (p = 0.32) (Fig. 2). The association
between viral load, as estimated by CT values, and illness was fur-
ther investigated using non-parametric ROC analyses (Figs. 3 and 4).
For GII, it can be seen that there was  a reasonable predictive power
of CT values, but not for GI.
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Fig. 1. NoV detection rate by month between July 2014 and April 2015 in Children from rural communities of Vhembe district, South Africa.
Table 3
Genotyping results using BLAST and Noronet tool.
Sample number Sequence name Detection Ct value Conﬁrmed Human Norovirus with BLAST Sequence similarity Genotype
30 KJP-30C-Venda-2014 GII 23.34 GII capsid 93–99% GII.4 variant
45  KJP-45C-Venda-2014 GII 20.54 GII capsid 78–81% GII.4 variant
148  KJP-148C-Venda-2014 GII 21.91 GII capsid 91–97% GII.14
139  KJP-139C-Venda-2014 GI 23.94 GI capsid 87–90% GI.4
168  KJP-168C-Venda-2015 GI 34.69 GI capsid 80–92% GI.5
H011 KJP-H011C-Venda-2015 GI 32.69 GI capsid 94–99% GI.4
Fig. 2. Comparison of Median CT values of NoV in symptomatic and asymptomatic children from rural communities of Vhembe district, South Africa.
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Fig. 3. ROC curve for inv CT values as predictors of diarrhea GII positive.
Fig. 4. ROC curve for inv CT values as p
Table 4
Sensitivities and speciﬁcities for using different CT value cut off levels for predicting
diarrhea in PCR positive NoV samples.
CT cut off value GI GII
Sensitivity/% Speciﬁcity/% Sensitivity/% Speciﬁcity/%
<40 95 11 92 13
<35  80 22 78 56




O<25  41 78 47 94
<20 15 100 8 100
Table 4 shows the sensitivity and speciﬁcity of using different
T values for GI and GII as predictors of symptoms. It can be seen
hat although sensitivity of the GI and GII analyses are similar, the
peciﬁcity for GI is much lower than for GII across all CT values.
verall it would appear that the CT values for GII adequately predictredictors of diarrhea GI positive.
illness whereas this is not the case for GI. Speciﬁcity is poor, even
for GII, except for CT values below 20.
5. Discussion
The main objective of this study was  to assess the NoV preva-
lence and compare the estimated viral load in asymptomatic
and symptomatic children in rural communities of Vhembe dis-
trict/South Africa. The results of this study revealed that the
detection rate of NoV in symptomatic cases was high (41.1%,
104/253) but was  not statistically different when compared to the
controls (36%, 18/50). Evidence that NoV-positivity was more com-
mon  in the symptomatic compared to the asymptomatic children
was not established in this study. Furthermore NoV positive cases




























































[J.P. Kabue et al. / Journal of C
Comparison of CT values of NoV genogroups revealed a lower
edian CT value (27.02) of NoV GII detected in symptomatic chil-
ren, compared to that recorded for the asymptomatic children
34.59), and this was statistically signiﬁcant. However, there was
o signiﬁcant difference in CT values between NoV positive cases
nd controls for NoV GI genogroup.
Even though the prevalence of GII is roughly the same in cases
nd controls, the estimated viral load is higher in cases. We  note
hat NoV GI genogroup, detected in both groups, did not exhibit
he same trend suggesting that GI is not a cause of disease in the
tudy population. The ROC analyses also revealed a considerable
redictive power of CT values for diarrhea GII positive, but not GI.
NoV-induced gastroenteritis has previously been associated
ith lower CT values (implying higher viral loads), than asymp-
omatic infections in several studies [26,12,13,27,9,14]. However,
o our knowledge this is the ﬁrst study reporting on the differences
n estimated viral load of GII and GI NoV positive cases and controls.
n real time PCR, CT levels are used as a surrogate measurement of
iral load in combination with standards of known quantities. In
his study, the inhibition that may  have affected the target CT val-
es, were monitored by the use of an internal control and all control
T values were within the 30–32 cycle range.
The ﬁndings of the study are concordant with several studies
hat reported NoV GII as the predominant genogroup involved in
linical cases, and circulating in communities worldwide [28–30].
The observation that the prevalence of Human NoV excretion
n stools is similar in both symptomatic and asymptomatic chil-
ren has been previously reported and raises questions about its
athogenic role in Africa [31–33]. These ﬁndings also indicate
hat asymptomatic infections could be a source of NoV outbreaks.
imilarly, Ayukekbong et al. [34] reported that in developing coun-
ries NoV infections are very common with comparable detection
ates observed in diarrhea cases and controls. However in a cross-
ectional study, it is easy to mis-classify substantial numbers
f post-symptomatic infections as asymptomatic infections even
hen the controls are deﬁned as absence of diarrhea symptoms in
he preceding 4 weeks [35–37].
The high detection rate of NoV in children living in rural com-
unities is likely to reﬂect their substantial exposure to enteric
athogens, probably as a result of poor sanitation and hygiene
ractices. Most of the children in the study population were from
ouseholds with a very low income and poor living conditions,
lthough comparable rates of NoV detection from outpatient chil-
ren in rural communities and semi-urban settings have been
eported previously in other developing countries such as Bolivia,
hina, Brazil and Mexico [38–40,17].
The ﬁndings of this study are inconsistent with previous studies
38,41] that found a substantial difference in the NoV detection
ates of both groups. However these studies were carried out in
emi-urban settings which are different from rural settings.
Children aged 13 to 24 months had the highest rates of NoV
ositivity relative to those of other age groups in this study. This
nding is consistent with other studies of outpatient children in
eveloping countries [42,39,43]. Young children between 13 and
4 months of age may  have more opportunities to be exposed to
oV-infected environments that children of other age groups [39],
oupled with the absence of toilet training.
One of the limitations of this study is the restricted num-
er of stool specimens from healthy controls. Also we  have not
ooked for other causes of gastroenteritis such as adenovirus, astro-
irus or bacterial and parasitic causes. Though we  have performed
ucleotides sequencing of ampliﬁed capsid fragment on some sam-
les at low virus concentration, the assay used in this study cannot
elp to differentiate Norovirus genotypes.
Our ﬁndings suggest that the difference between asymptomatic
nd symptomatic children in African populations may  relate to the
[
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NoV viral load. The difference in estimated viral load of NoVs GI
relative to GII observed in this study also supports the concept that
transmissibility via the fecal-oral route and viral infectivity may  be
lower for GI than GII [44].
The study ﬁndings may  have implications for the diagnosis of
NoV disease and future vaccine development, which may  only need
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